MD2851G2 - Inhibitor al leucemiei umane mieloide în baza tricloracetatului dimeric asimetric de cobalt - Google Patents

Inhibitor al leucemiei umane mieloide în baza tricloracetatului dimeric asimetric de cobalt Download PDF

Info

Publication number
MD2851G2
MD2851G2 MDA20040199A MD20040199A MD2851G2 MD 2851 G2 MD2851 G2 MD 2851G2 MD A20040199 A MDA20040199 A MD A20040199A MD 20040199 A MD20040199 A MD 20040199A MD 2851 G2 MD2851 G2 MD 2851G2
Authority
MD
Moldova
Prior art keywords
aqua
cobalt
bis
inhibitor
myeloid leukemia
Prior art date
Application number
MDA20040199A
Other languages
English (en)
Russian (ru)
Other versions
MD2851F1 (ro
Inventor
Аурелиан ГУЛЯ
Дональд ПОЙРИЕР
Дженни РОЙ
Лилия ПОПОВСКИ
Виктор ЦАПКОВ
Original Assignee
Государственный Университет Молд0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Университет Молд0 filed Critical Государственный Университет Молд0
Priority to MDA20040199A priority Critical patent/MD2851G2/ro
Publication of MD2851F1 publication Critical patent/MD2851F1/ro
Publication of MD2851G2 publication Critical patent/MD2851G2/ro

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la aplicarea combinaţiilor coordinative în medicină şi anume la utilizarea (µ-aqua)-bis(µ-tricloracetato)-tri(aqua)cobalt-aqua-bis(tricloracetato)cobalt monohidrat în calitate de inhibitor al leucemiei umane mieloide.Esenţa invenţiei constă în aceea că în calitate de inhibitor al leucemiei umane mieloide se revendică (µ-aqua)-bis(µ-tricloracetato)-tri(aqua)cobalt-aqua-bis(tricloracetato)cobalt monohidrat cu formula :Rezultatul invenţiei constă în stabilirea la cunoscutul (µ-aqua)-bis(µ-tricloracetato)-tri(aqua)cobalt-aqua-bis(tricloracetato)cobalt monohidrat a activităţii anticanceroase, care depăşeşte de 1,25...1,35 ori caracteristicile analoage ale dimerilor trihidratului aquaetilendiamintetraacetatobismutatului(III) de 1,6-dinitrotetraamincobalt(III) şi dihidratului etilendiamintetraacetatobismutatului(III) de oxalatotetraamincobalt(III) (analogului).
MDA20040199A 2004-08-12 2004-08-12 Inhibitor al leucemiei umane mieloide în baza tricloracetatului dimeric asimetric de cobalt MD2851G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20040199A MD2851G2 (ro) 2004-08-12 2004-08-12 Inhibitor al leucemiei umane mieloide în baza tricloracetatului dimeric asimetric de cobalt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20040199A MD2851G2 (ro) 2004-08-12 2004-08-12 Inhibitor al leucemiei umane mieloide în baza tricloracetatului dimeric asimetric de cobalt

Publications (2)

Publication Number Publication Date
MD2851F1 MD2851F1 (ro) 2005-09-30
MD2851G2 true MD2851G2 (ro) 2006-04-30

Family

ID=35057542

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20040199A MD2851G2 (ro) 2004-08-12 2004-08-12 Inhibitor al leucemiei umane mieloide în baza tricloracetatului dimeric asimetric de cobalt

Country Status (1)

Country Link
MD (1) MD2851G2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4215C1 (ro) * 2012-07-09 2013-11-30 Государственный Университет Молд0 Inhibitor al leucemiei mieloide umane în bază de N-(4-(5-(piridin-2-il)-4,5-dihidro-1H-pirazol-3-il)fenil)-2-(piridin-2-ilmetilen)-hidrazincarbotioamidă

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3098G2 (ro) * 2006-01-03 2007-02-28 Государственный Университет Молд0 Dihidrat de di(?-Ofenoxi)-di[N-(2-oxi-1-benzal)-N1-?-oxifuralhidrazino(2-)cupru] cu proprietăţi de inhibitor al leucemiei mieloide umane

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2786G2 (ro) * 2004-05-11 2006-02-28 Государственный Университет Молд0 Inhibitori ai leucemiei umane mieloide în bază de combinaţii coordinative heteronucleare ale cobaltului(III) si bismutului(III)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2786G2 (ro) * 2004-05-11 2006-02-28 Государственный Университет Молд0 Inhibitori ai leucemiei umane mieloide în bază de combinaţii coordinative heteronucleare ale cobaltului(III) si bismutului(III)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4215C1 (ro) * 2012-07-09 2013-11-30 Государственный Университет Молд0 Inhibitor al leucemiei mieloide umane în bază de N-(4-(5-(piridin-2-il)-4,5-dihidro-1H-pirazol-3-il)fenil)-2-(piridin-2-ilmetilen)-hidrazincarbotioamidă

Also Published As

Publication number Publication date
MD2851F1 (ro) 2005-09-30

Similar Documents

Publication Publication Date Title
UA74443C2 (uk) Ліганди 5-нт рецептора та їх використання
GB2420559B (en) Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
PL1791532T3 (pl) Kompozycja w mikropeletkach o kontrolowanym uwalnianiu substancji fizjologicznie czynnych, sposób jej wytwarzania i jej zastosowanie w dziedzinie zootechniki
MY140398A (en) 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
EP2014669A3 (en) Compositions and methods for cancer
EP1623985A3 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
MXPA06003222A (es) Agente antitumoral que comprende un inhibidor de histona desacetilasa y un inhibidor de topoisomerasa ii.
GEP20094844B (en) 3-aminocyclopentane carboxamides as modulators of chemokine receptors
GB0111186D0 (en) Novel compounds
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
GEP20094843B (en) 3-aminocyclopentane carboxamides as modulators of chemokine receptors
EP1962843A4 (en) USE OF PARP-1 INHIBITORS
EP2392322A3 (en) Dosing regimes for trans-clomiphene
ZA200500908B (en) Ruthenium anticancer complexes
AU2003271807A8 (en) Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
YU38103A (sh) Nova jedinjenja askorbinske kiseline, postupci sinteze i način njihove primene
TW200726763A (en) Novel compound
GEP20043226B (en) C7 Carbonate Substituted Taxanes as Antitumor Agents, Pharmaceutical Compositions Containing the Same and Use Thereof as Agents to Inhibit Tumor Growth
MD2851F1 (ro) Inhibitor al leucemiei umane mieloide in baza tricloracetatului dimeric asimetric de cobalt
WO2005056510A3 (en) Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
PL1718651T3 (pl) Pochodne 7H-pirolopirymidyny
DE602006018883D1 (de) Tricylische 1,2,4-triazinoxide und zusammensetzungen davon zur therapeutischen anwendung bei krebsbehandlungen
MD2323F1 (ro) Utilizarea bromurii de S-etilizotiouroniu (izoturon) in calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine in cazul miomului uterin
GB0326518D0 (en) Anti-cancer compounds

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees